American Head & Neck Society
Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.
Kaiser Permanente
9961 Sierra Ave
Fontana
CA
92335
United States
Phone:
Email: [email protected]
Web Site:
Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery
Medical School: Loma Linda University
Residency: Loma Linda University
Fellowship: University of California Los Angeles
Stanford University
801 Welch Road
Palo Alto
California
94304
United States
Phone:
Email:
Web Site:
Endocrine Surgery, Head and Neck Surgeon
Resident physician at Stanford Otolaryngology–Head & Neck Surgery (2016-2021)
Future Head & Neck / Endocrine Surgical Oncology fellow at MD Anderson (2021-2022)
GREATER KAILASH HOSPITAL
Beside Hotel shreemaya, R.N.T. Marg, Indore, M.P.
.
Indore
Madhya pradesh
452016
India
Phone: +919584284566
Email: [email protected]
Web Site:
Head and Neck Research, Head and Neck Surgeon, Oral Surgeon, Reconstructive Head & Neck Surgery
I am a dedicated consultant head & neck oncosurgeon/ reconstruction surgeon / oral & maxillofacial surgeon with enriched experience & expertise of nearly 6 years in handling difficult cases, studying the case history & finding out medical solutions. Over the years, I have performed more than 700 major / supra major onco surgeries.
I am an academically astute with credentials as MDS; MFDS RCPS (Glasgow); FDS RCS(Lon); FHNCS; FADI; FIIHNO; and FIFHNOS, U.S, presently pursuing Doctor of Philosophy (Ph.D.) in Oral & Maxillofacial Surgery from Saveetha University. I am passionate about improving longevity of patients afflicted with high-risk & complex carcinomas. During my associations I have gained a strong experience in liaising with authorities, patients and with national and international organizations.
Evaluation of clinico-pathological parameters and Epidermal growth factor receptor status to create a mathematical model for prognosis of oral squamous cell carcinomas.
..
Oregon Health & Science University
3181 Southwest Sam Jackson Park Road
PV-01
Portland
Oregon
97239
United States
Phone: (503)494-2544
Email:
Web Site: https://www.ohsu.edu/ent/thyroid-and-parathyroid-center
Endocrine Surgery, Head and Neck Surgeon
Dr. Shindo serves as the co-director of the Thyroid and Parathyroid Program, consulting with patients and providing a full range of diagnosis and surgical treatment services to patients with thyroid and parathyroid disorders.Dr. Shindo has special expertise in the treating complicated thyroid and parathyroid conditions, bringing together the expertise of doctors from several specialties when necessary. She has performed pioneering work with new treatments, including minimally invasive parathyroid surgery done under local anesthesia with video technology. She is a nationally and internationally well recognized head and neck endocrine surgeon.
Education
Residency: Otolaryngology – head and neck surgery, University of Southern California Medical Center, 1989
Fellowship: Head and neck oncologic surgery, Northwestern University Hospital, 1991
Certifications: American Board of Otolaryngology, 1989
Winship Cancer Institute at Emory University
550 Peachtree Street Northeast
11th Floor Otolaryngology
Atlanta
Georgia
30308
United States
Phone:
Email:
Web Site:
Head and Neck Research, Head and Neck Surgeon
Dr. Schmitt obtained her Medical Degree from Washington University School of Medicine in St. Louis, Missouri. She completed her general surgery internship, a research fellowship and her residency in otolaryngology at University of Washington in Seattle, Washington. She also completed a fellowship in head and neck surgery and tumor biology at University of Pittsburgh in Pittsburgh, Pennsylvania. Dr. Schmitt was on faculty at Johns Hopkins University and the National Institute on Deafness and Other Communication Disorders (NIDCD), NIH, before joining the faculty at Emory University in 2020.
Dr. Schmitt’s research interest is in characterizing immune effects of cytotoxic chemotherapy and designing optimal combinations of chemotherapy and immunotherapy for head and neck cancer.
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer. Ye W, Gunti S, Allen CT, Hong Y, Clavijo PE, Van Waes C, Schmitt NC. Oncoimmunology. 2020 Jan 9;9(1):1710398.
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. Park SJ, Ye W, Xiao R, Silvin C, Padget M, Hodge JW, Van Waes C, Schmitt NC. Oral Oncol. 2019 Aug;95:127-135.
Cisplatin alters anti-tumor immunity and synergizes with PD-1/PD-L1 inhibition in head and neck squamous cell carcinoma. Tran L, Allen CT, Xiao R, Moore E, Davis R, Park SJ, Spielbauer K, Van Waes C, Schmitt NC. Cancer Immunol Res 2017;5: 1141-1151.
PD-1 inhibition minimally impacts cisplatin-induced toxicities in a murine model. Spielbauer K, Cunningham L, Schmitt N. Otolaryngol Head and Neck Surg 2018; 159:343-346.
Antagonist of cIAP1/2 and XIAP synergizes with radiation therapy and PD-1 blockade to enhance anti-tumor immunity. Xiao R, Allen CT, Tran L, Patel P, Park SJ, Chen Z, Van Waes C, Schmitt NC. Oncoimmunology 2018; 7:e1471440.